Neuromodulation and antenatal depression: A review

Neuropsychiatric Disease and Treatment

Volumn 11, Issue , 2015, Pages 975-982

  Kim, Deborah R ^a   Snell, Jessica L ^a   Ewing, Grace C ^a   O’Reardon, John ^b  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

^b ROWAN UNIVERSITY   (United States)

Author keywords

Antenatal depression; Depression; Electroconvulsive therapy; Perinatal; Pregnancy; Transcranial magnetic stimulation

Indexed keywords

ARTICLE; BRAIN DEPTH STIMULATION; ELECTROCONVULSIVE THERAPY; FIRST TRIMESTER PREGNANCY; HUMAN; NEUROMODULATION; PERINATAL DEPRESSION; SECOND TRIMESTER PREGNANCY; SYSTEMATIC REVIEW; THIRD TRIMESTER PREGNANCY; TRANSCRANIAL DIRECT CURRENT STIMULATION; TRANSCRANIAL MAGNETIC STIMULATION; VAGUS NERVE STIMULATION;

EID: 84929173642     PISSN: None     EISSN: 11782021     Source Type: Journal    
DOI: 10.2147/NDT.S80480     Document Type: Article

References (67)

1. George MS, Nahas Z, Borckardt JJ, et al. Brain stimulation for the treatment of psychiatric disorders. Curr Opin Psychiatry. 2007;20(3):250–254. [discussion 247–249].
2. Radhu N, de Jesus DR, Ravindran LN, Zanjani A, Fitzgerald PB, Daskalakis ZJ. A meta-analysis of cortical inhibition and excitability using transcranial magnetic stimulation in psychiatric disorders. Clin Neurophysiol. 2013;124(7):1309–1320.
3. Schlaepfer TE, Bewernick BH. Neuromodulation for treatment resistant depression: state of the art and recommendations for clinical and scientific conduct. Brain Topogr. 2014;27(1):12–19.
4. Bennett HA, Einarson A, Taddio A, Koren G, Einarson TR. Prevalence of depression during pregnancy: systematic review. Obstet Gynecol. 2004;103(4):698–709.
5. Marcus SM, Flynn HA, Blow F, Barry K. A screening study of antidepressant treatment rates and mood symptoms in pregnancy. Arch Womens Ment Health. 2005;8(1):25–27.
6. Gavin NI, Gaynes BN, Lohr KN, Meltzer-Brody S, Gartlehner G, Swinson T. Perinatal depression: a systematic review of prevalence and incidence. Obstet Gynecol. 2005;106(5 pt 1):1071–1083.
7. Kim DR, Sockol LE, Sammel MD, Kelly C, Moseley M, Epperson CN. Elevated risk of adverse obstetric outcomes in pregnant women with depression. Arch Womens Ment Health. 2013;16(6):475–482.
8. Grote NK, Bridge JA, Gavin AR, Melville JL, Iyengar S, Katon WJ. A meta-analysis of depression during pregnancy and the risk of preterm birth, low birth weight, and intrauterine growth restriction. Arch Gen Psychiatry. 2010;67(10):1012–1024.
9. Pearlstein T. Perinatal depression: treatment options and dilemmas. J Psychiatry Neurosci. 2008;33(4):302–318.
10. Wisner KL, Sit DK, Hanusa BH, et al. Major depression and antidepressant treatment: impact on pregnancy and neonatal outcomes. Am J Psychiatry. 2009;166(5):557–566.
11. Wisner KL, Zarin DA, Holmboe ES, et al. Risk-benefit decision making for treatment of depression during pregnancy. Am J Psychiatry. 2000;157(12):1933–1940.
12. Walton GD, Ross LE, Stewart DE, Grigoriadis S, Dennis CL, Vigod S. Decisional conflict among women considering antidepressant medication use in pregnancy. Arch Womens Ment Health. 2014;17(6):493–501.
13. Kim DR, Sockol L, Barber JP, et al. A survey of patient acceptability of repetitive transcranial magnetic stimulation (TMS) during pregnancy. J Affect Disord. 2011;129(1–3):385–390.
14. Goodman JH. Women’s attitudes, preferences, and perceived barriers to treatment for perinatal depression. Birth. 2009;36(1):60–69.
15. Petersen I, Gilbert RE, Evans SJ, Man SL, Nazareth I. Pregnancy as a major determinant for discontinuation of antidepressants: an analysis of data from the health improvement network. J Clin Psychiatry. 2011;72(7):979–985.
16. Margulis AV, Kang EM, Hammad TA. Patterns of prescription of antidepressants and antipsychotics across and within pregnancies in a population-based UK cohort. Matern Child Health J. 2014;18(7):1742–1752.
17. Sockol LE, Epperson CN, Barber JP. A meta-analysis of treatments for perinatal depression. Clin Psychol Rev. 2011;31(5):839–849.
18. Spinelli MG, Endicott J, Leon AC, et al. A controlled clinical treatment trial of interpersonal psychotherapy for depressed pregnant women at 3 New York city sites. J Clin Psychiatry. 2013;74(4):393–399.
19. O’Mahen H, Himle JA, Fedock G, Henshaw E, Flynn H. A pilot randomized controlled trial of cognitive behavioral therapy for perinatal depression adapted for women with low incomes. Depress Anxiety. 2013;30(7):679–687.
20. Fink M, Kellner CH, McCall WV. The role of ECT in suicide prevention. J ECT. 2014;30(1):5–9.
21. Weiner RD, Coffey CE, Fochtmann L, et al, editors. Recommendations for Treatment, Training and Privileging. 2nd ed. Washington, D.C: American Psychiatric Press, American Psychiatric Association; 2001.
22. Kellner CH, Pasculli RM, Briggs MC. Treatment of depression during pregnancy. J ECT. 2012;28(3):195–196.
23. Miller LJ. Use of electroconvulsive therapy during pregnancy. Hosp Community Psychiatry. 1994;45(5):444–450.
24. Anderson EL, Reti IM. ECT in pregnancy: a review of the literature from 1941 to 2007. Psychosom Med. 2009;71(2):235–242.
25. Leiknes KA, Cooke MJ, Jarosch-von Schweder L, Harboe I, Hoie B. Electroconvulsive therapy during pregnancy: A systematic review of case studies. Arch Womens Ment Health. 2013;18:1–39.
26. De Asis SJ, Helgeson L, Ostroff R. The use of propofol to prevent fetal deceleration during electroconvulsive therapy treatment. J ECT. 2013;29(4):e57–e58.
27. Macones GA, Hankins GD, Spong CY, Hauth J, Moore T. The 2008 national institute of child health and human development workshop report on electronic fetal monitoring: Update on definitions, interpretation, and research guidelines. Obstet Gynecol. 2008;112(3):661–666.
28. Bulbul F, Copoglu US, Alpak G, et al. Electroconvulsive therapy in pregnant patients. Gen Hosp Psychiatry. 2013;35(6):636–639.
29. O’Reardon JP, Cristancho MA, von Andreae CV, Cristancho P, Weiss D. Acute and maintenance electroconvulsive therapy for treatment of severe major depression during the second and third trimesters of pregnancy with infant follow-up to 18 months: case report and review of the literature. J ECT. 2011;27(1):e23–e26.
30. Moya F, Kvisselgaard N. The placental transmission of succinylcholine. Anesthesiology. 1961;22:1–6.
31. Rabheru K. The use of electroconvulsive therapy in special patient populations. Can J Psychiatry. 2001;46(8):710–719.
32. Forssman H. Follow-up study of sixteen children whose mothers were given electric convulsive therapy during gestation. Acta Psychiatr Neurol Scand. 1955;30(3):437–441.
33. Smith S. The use of electroplexy (E.C.T.) in psychiatric syndromes complicating pregnancy. J Ment Sci. 1956;102(429):796–800.
34. Impastato DJ, Gabriel AR, Lardaro HH. Electric and insulin shock therapy during pregnancy. Dis Nerv Syst. 1964;25:542–546.
35. Halmo M, Spodniakova B, Nosalova P. Fetal spasms after the administration of electroconvulsive therapy in pregnancy: our experience. J ECT. 2014;30(3):e24–e26.
36. Salzbrenner S, Breeden A, Jarvis S, Rodriguez W. A 48-year-old woman primigravid via in vitro fertilization with severe bipolar depression and preeclampsia treated successfully with electroconvulsive therapy. J ECT. 2011;27(1):e1–e3.
37. Blaser JA, Allan GM. Acetaminophen in pregnancy and future risk of ADHD in offspring. Can Fam Physician. 2014;60(7):642.
38. Liew Z, Ritz B, Rebordosa C, Lee PC, Olsen J. Acetaminophen use during pregnancy, behavioral problems, and hyperkinetic disorders. JAMA Pediatr. 2014;168(4):313–320.
39. Thompson JM, Waldie KE, Wall CR, Murphy R, Mitchell EA; ABC study group. Associations between acetaminophen use during pregnancy and ADHD symptoms measured at ages 7 and 11 years. PLoS One. 2014;9(9):e108210.
40. Jablensky AV, Morgan V, Zubrick SR, Bower C, Yellachich LA. Pregnancy, delivery, and neonatal complications in a population cohort of women with schizophrenia and major affective disorders. Am J Psychiatry. 2005;162(1):79–91.
41. Orr ST, Miller CA. Maternal depressive symptoms and the risk of poor pregnancy outcome: review of the literature and preliminary findings. Epidemiol Rev. 1995;17(1):165–171.
42. Nilsson E, Lichtenstein P, Cnattingius S, Murray RM, Hultman CM. Women with schizophrenia: pregnancy outcome and infant death among their offspring. Schizophr Res. 2002;58(2–3):221–229.
43. Paluzzi A, Bain PG, Liu X, Yianni J, Kumarendran K, Aziz TZ. Pregnancy in dystonic women with in situ deep brain stimulators. Mov Disord. 2006;21(5):695–698.
44. Groves DA, Brown VJ. Vagal nerve stimulation: a review of its applications and potential mechanisms that mediate its clinical effects. Neurosci Biobehav Rev. 2005;29(3):493–500.
45. Husain MM, Stegman D, Trevino K. Pregnancy and delivery while receiving vagus nerve stimulation for the treatment of major depression: a case report. Ann Gen Psychiatry. 2005;4:16.
46. Houser MV, Hennessy MD, Howard BC. Vagal nerve stimulator use during pregnancy for treatment of refractory seizure disorder. Obstet Gynecol. 2010;115(2 pt 2):417–419.
47. Gaynes BN, Lloyd SW, Lux L, et al. Repetitive transcranial magnetic stimulation for treatment-resistant depression: a systematic review and meta-analysis. J Clin Psychiatry. 2014;75(5):477–489. [quiz 489].
48. Rossi S, Hallett M, Rossini PM, Pascual-Leone A; Safety of TMS Consensus Group. Safety, ethical considerations, and application guidelines for the use of transcranial magnetic stimulation in clinical practice and research. Clin Neurophysiol. 2009;120(12):2008–2039.
49. Janicak PG, O’Reardon JP, Sampson SM, et al. Transcranial magnetic stimulation in the treatment of major depressive disorder: A comprehensive summary of safety experience from acute exposure, extended exposure, and during reintroduction treatment. J Clin Psychiatry. 2008;69(2):222–232.
50. Kim DR, Wang E. Prevention of supine hypotensive syndrome in pregnant women treated with transcranial magnetic stimulation. Psychiatry Res. 2014;218(1–2):247–248.
51. Kim DR, Epperson N, Paré E, et al. An open label pilot study of transcranial magnetic stimulation for pregnant women with major depressive disorder. J Womens Health (Larchmt). 2011;20(2):255–261.
52. Nahas Z, Bohning DE, Molloy MA, Oustz JA, Risch SC, George MS. Safety and feasibility of repetitive transcranial magnetic stimulation in the treatment of anxious depression in pregnancy: a case report. J Clin Psychiatry. 1999;60(1):50–52.
53. Klirova M, Novak T, Kopecek M, Mohr P, Strunzova V. Repetitive transcranial magnetic stimulation (rTMS) in major depressive episode during pregnancy. Neuro Endocrinol Lett. 2008;29(1):69–70.
54. Zhang X, Liu K, Sun J, Zheng Z. Safety and feasibility of repetitive transcranial magnetic stimulation (rTMS) as a treatment for major depression during pregnancy. Arch Womens Ment Health. 2010;13(4):369–370.
55. Hamilton M. Development of a rating scale for primary depressive illness. Br J Soc Clin Psychol. 1967;6(4):278–296.
56. Guy W. Clinical global impression scale. Psychiatry. 1976;4(7): 28–37.
57. Beck AT, Epstein N, Brown G, Steer RA. An inventory for measuring clinical anxiety: psychometric properties. J Consult Clin Psychol. 1988;56(6):893–897.
58. Hızlı Sayar G, Ozten E, Tufan E, et al. Transcranial magnetic stimulation during pregnancy. Arch Womens Ment Health. 2014;17(4):311–315.
59. Eryılmaz G, Hızlı Sayar G, Ozten E, et al. Follow-up study of children whose mothers were treated with transcranial magnetic stimulation during pregnancy: preliminary results. Neuromodulation. 2014.
60. Burton C, Gill S, Clarke P, Galletly C. Maintaining remission of depression with repetitive transcranial magnetic stimulation during pregnancy: a case report. Arch Womens Ment Health. 2014;17(3):247–250.
61. Poreisz C, Boros K, Antal A, Paulus W. Safety aspects of transcranial direct current stimulation concerning healthy subjects and patients. Brain Res Bull. 2007;72(4–6):208–214.
62. Shiozawa P, Fregni F, Benseñor IM, et al. Transcranial direct current stimulation for major depression: an updated systematic review and meta-analysis. Int J Neuropsychopharmacol. 2014;17(9):1443–1452.
63. Vigod S, Dennis CL, Daskalakis Z, et al. Transcranial direct current stimulation (tDCS) for treatment of major depression during pregnancy: Study protocol for a pilot randomized controlled trial. Trials. 2014;15:366.
64. Yonkers KA, Wisner KL, Stewart DE, et al. The management of depression during pregnancy: a report from the American psychiatric association and the American college of obstetricians and gynecologists. Gen Hosp Psychiatry. 2009;31(5):403–413.
65. Chen J, Zhou C, Wu B, et al. Left versus right repetitive transcranial magnetic stimulation in treating major depression: A meta-analysis of randomised controlled trials. Psychiatry Res. 2013;210(3):1260–1264.
66. Berlim MT, van den Eynde F, Tovar-Perdomo S, Daskalakis ZJ. Response, remission and drop-out rates following high-frequency repetitive transcranial magnetic stimulation (rTMS) for treating major depression: A systematic review and meta-analysis of randomized, double-blind and sham-controlled trials. Psychol Med. 2014;44(2):225–239.
67. Gahr M, Blacha C, Connemann BJ, Freudenmann RW, Schonfeldt-Lecuona C. Successful treatment of major depression with electroconvulsive therapy in a pregnant patient with previous non-response to prefrontal rTMS. Pharmacopsychiatry. 2012;45(2):79–80.